Skip to main content

MHRA-Compliant Pharmaceutical Sourcing & PLPI Licensing

Trusted wholesale distribution of EU-GMP medicines to UK healthcare providers. GDP-compliant, cold-chain logistics, full regulatory transparency.

MHRA Regulated
EU-GMP Sourcing
GDP Compliance
Cold-Chain Certified
UK Registered

Three-Pillar Sourcing Strategy

A comprehensive pharmaceutical sourcing framework combining direct partnerships, regulatory expertise, and verified EU networks.

Manufacturing

Direct GMP Partnerships

Verified manufacturers in India and EU with full quality assurance documentation. Direct sourcing model ensures cost efficiency and supply reliability with transparent auditing and regulatory compliance.

Regulatory

PLPI Licensing Pathway

MHRA-approved Parallel Import Product Information licensing for EU-authorised medicines supplied to UK with compliant labelling and patient information leaflets. End-to-end regulatory management.

Distribution

European Wholesaler Network

Verified EU supplier network (Germany, Poland, Romania, Netherlands) with GDP-aligned warehousing, temperature-controlled transport and independent quality audits. Multi-jurisdictional coverage.

Comprehensive Solutions by Audience

Curated commercial models, logistics architectures and regulatory support tailored to the operating realities of NHS organisations, pharmacies and licensed wholesalers.

Healthcare Providers

NHS Trusts & Hospital Providers

Enterprise procurement partners for acute, specialist and teaching hospitals seeking predictable supply, measurable savings and full regulatory traceability.

  • Commercial model: Framework-aligned pricing, tender-linked discounts, and portfolio-based negotiations.
  • Typical efficiencies: 20–35% cost efficiencies, subject to product mix, tender structure and volumes.
  • Risk management: Dual-sourcing options, contingency stock and batch-level documentation for audits.
  • Service layer: Dedicated key account lead, scheduled business reviews and structured MI reporting.
Retail Pharmacy

Independent & Small Chain Pharmacies

A curated wholesale portfolio for high-street and regional pharmacies balancing margin protection with dependable service levels.

  • Distribution model: Low minimum order quantities with the option to aggregate across branches.
  • Digital experience: Real-time availability, indicative pricing view, and on-demand access to SmPC/PIL packs.
  • Logistics: 2–3 working day delivery across the UK with temperature-controlled options where required.
  • Support: Named contact for escalation, stock enquiry and product-switch guidance.
Trade Partners

Licensed Wholesalers & Distributors

Strategic B2B partnerships for wholesalers looking to augment their portfolio with EU-GMP products and PLPI-licensed lines.

  • Network access: Entry into NovaPharm's vetted EU and India GMP network under clear commercial frameworks.
  • Compliance fabric: GDP-aligned processes, batch-level traceability and audit-ready documentation packs.
  • Operating model: Contract-based supply with agreed service levels, volume commitments and escalation paths.
  • Value creation: Portfolio differentiation, expanded therapeutic coverage and shared pipeline visibility.

NHS Cost Savings Calculator

Estimated Annual Savings

£0
Enter your organisation details to calculate

Professional Global Supply Chain & Logistics

Enterprise-grade pharmaceutical logistics infrastructure with real-time batch tracking, temperature validation, and pharmacovigilance integration.

Regulatory-First End-to-End Supply Chain Process

1

Supplier Qualification & Audit

Verify EU-GMP certification, conduct on-site audits, confirm GDP compliance, review Quality Certificates and manufacturing records

Timeline: 4-6 weeks
2

Batch Documentation & Certificate of Analysis

Certificate of Analysis (CoA), Quality Overall Summary (QOS), batch traceability records, full manufacturing documentation

Timeline: Pre-shipment verification
3

MHRA PLPI Regulatory Filing

MHRA PLPI licensing, packaging verification, Patient Information Leaflet translation, labelling compliance and regulatory submission

Timeline: 6-12 weeks
4

Cold-Chain Logistics & Storage

Temperature-validated storage (2-8°C for biologics), Polar Speed partnership, real-time GPS tracking, humidity monitoring

Timeline: Continuous real-time monitoring
5

Last-Mile & Customs Clearance

UPS global distribution, signature-on-delivery tracking, customs brokerage, hazmat certification and compliance documentation

Timeline: 2-3 working days (UK delivery)
6

Pharmacovigilance & Adverse Events Management

24/7 PV monitoring, MHRA Yellow Card integration, adverse event management, batch recall protocols and safety reporting

Timeline: 24-hour response SLA

Enterprise Logistics & Compliance Partners

Strategic partnerships with world-class logistics providers and compliance specialists ensuring pharmaceutical excellence at every step.

Cold Chain

Polar Speed

EU-GMP Cold-Chain Specialist

Enterprise cold-chain partner with 15+ years pharmaceutical logistics expertise. Specializes in biologics and temperature-sensitive pharmaceuticals with 24/7 monitoring and real-time tracking across all EU territories.

Global Logistics

UPS Logistics

Global Distribution Leader

220+ countries distribution network with SOC 2 Type II compliance. International pharmaceutical logistics expertise with hazmat handling certification and dedicated pharmaceutical account management.

Compliance

NovaPharm In-House Compliance

24/7 Regulatory Quality Assurance

Dedicated pharmacovigilance team with round-the-clock adverse event monitoring. GxP-compliant systems, regulatory documentation archive, batch traceability and MHRA reporting integration.

Business Model & Licensed Medicines Portfolio

Integrated revenue streams combining distribution, product portfolio, and regulatory services.

Distribution

B2B Pharmaceutical Distribution

Direct supply to NHS trusts, hospitals, pharmacies, and licensed wholesalers. Wholesale pricing with volume-based discounts and institutional pricing frameworks. Transparent cost structures.

Product Portfolio

Licensed Medicines Portfolio

A growing portfolio of licensed and in-development pharmaceutical products across oral and liquid dosage forms. Specialization in specialty therapeutic areas with approved and pipeline formulations.

Regulatory Services

PLPI Licensing & Regulatory

MHRA PLPI application support, documentation preparation, patient information leaflet translation, and labelling compliance services. Full regulatory pathway expertise.

Value-Added Services

Supply Chain Solutions

Cold-chain logistics, batch traceability, pharmacovigilance support, regulatory documentation, and compliance audit services. Comprehensive operational support.

Market Entry

In-Licensing Partnerships

End-to-end UK market entry for EU-GMP manufacturers — regulatory pathway mapping, PLPI filings, compliant labelling, and NHS distribution onboarding.

Supply Network

Out-Licensing Agreements

Commercial out-licensing and regional distribution agreements — contract structuring, rights management, and performance-based supply arrangements with GDP-certified logistics.

Tech-Pharma Innovation Roadmap

Strategic three-pillar framework for Tech-Pharma transformation — an AI-enabled roadmap shifting NovaPharm from compliance-first distribution to an integrated technology-driven pharmaceutical enterprise.

A three-phase roadmap combining data & analytics, regulatory automation, and commercial scale to deliver efficiency, regulatory assurance and sustainable growth.

1

Foundations

GMP supplier qualification, digital QMS, GDP-compliant warehousing and baseline analytics infrastructure.

  • Time-to-market reduction: 20%
  • Regulatory errors reduction: 40%
  • Supplier compliance: 100%
  • Documentation automation: 60%
2

Scale

Automated PLPI workflows, API integrations with distributors & hospitals, advanced demand forecasting and real-time tracking.

  • On-Time-In-Full (OTIF): +10–15%
  • Inventory turns: +25%
  • Order processing: -50%
  • Customer satisfaction: +35%
3

Integration

Embedded AI for pricing/tender optimisation, real-time PV monitoring, and value-based contracting with predictive analytics.

  • Revenue uplift: +8–12%
  • Gross margin improvement: +3–6pp
  • Market share growth: +18%
  • AI automation: 70%

Global Presence & Operational Footprint

NovaPharm Healthcare operates across 3 continents with verified supplier networks and regulatory expertise spanning MHRA, EU, USFDA, TGA, and SAHPRA (South Africa) — and direct GMP partnerships in India.

United Kingdom

UK Headquarters

Feltham, London

Flat 72 Archer Court, 21 High Street, Feltham, TW13 4AG

Operations: MHRA regulatory affairs, PLPI licensing, supply chain coordination, 24/7 pharmacovigilance

European Union

EU Supplier Network

Germany, Poland, Romania, Netherlands

4+ verified EU-GMP wholesale dealers and manufacturers

Services: Batch sourcing, GDP compliance, quality documentation, regulatory liaison

India

GMP Manufacturing

Direct Manufacturer Partnerships

Verified USFDA & MHRA-approved GMP facilities

Services: Formulation development, manufacturing commissioning, quality assurance, cost optimization

Regulatory Expertise Across Jurisdictions

🇬🇧
MHRA
PLPI Licensing
🇪🇺
EU-GMP
Manufacturing
🇮🇳
India
GMP Partnerships
🇺🇸
USFDA
Regulation
🇦🇺
TGA
Australian
🇿🇦
SAHPRA
South Africa

Executive Leadership

Industry leaders with demonstrated responsibility for regulatory compliance, commercial operations, and scientific governance.

Vishal Om Prakash Chakravarty

Vishal Om Prakash Chakravarty

Founder & CEO

Pharmaceutical entrepreneur with 5+ years PLPI licensing expertise, GMP supplier qualification and oncology specialization. Drives strategic vision for UK market entry.

Prabhakar Vitthal Lahare

Prabhakar Vitthal Lahare

Chief Operations Officer

27+ years pharmaceutical operations expertise, 18+ years leadership. Oversees global supply chain, QMS, and operational excellence across MHRA, EU, USFDA, TGA jurisdictions.

Dr. Girish Shantilal Achliya
Dr. Girish Achliya

Dr. Girish Shantilal Achliya

Chief Scientific Officer

M.Pharm, PhD, JD. 25+ years innovation, 40+ patent inventions. Leads formulation development, regulatory submissions, GMP compliance and portfolio strategy.

Dr. Helly Kamlesh Panchal

Dr. Helly Kamlesh Panchal

Medical Advisor

MD, Pharmacovigilance Specialist. Ensures clinical safety and efficacy standards across all products and operations. Leads 24/7 PV protocols and MHRA compliance.

24/7 Pharmacovigilance & Safety Reporting

Real-time adverse event monitoring and MHRA Yellow Card reporting

pv@novapharmhealthcare.com

24/7 monitored. Response within 4 hours during business hours, 24 hours maximum.

Information to Include

  • Patient age and gender (if available)
  • Suspected medicine(s) - name, strength, batch number
  • Adverse event description and onset date
  • Outcome and severity (mild, moderate, serious)
  • Reporter name and contact information

Reporting Standards

  • EU guidelines compliance (DIR 2001/83/EC)
  • MHRA Yellow Card Scheme integration
  • ICH E2A and E2B standards
  • GVP Module VI aligned processes

Get in Touch

Contact NovaPharm Healthcare to discuss sourcing requirements, regulatory support, or supply partnerships.

General Inquiries

vishal@novapharmhealthcare.com

Pharmacovigilance (24/7)

pv@novapharmhealthcare.com

Registered Office

Feltham, London TW13 4AG, UK